Home Endo To Purchase Par Pharmaceutical
 

Keywords :   


Endo To Purchase Par Pharmaceutical

2015-05-19 10:32:25| Biotech - Topix.net

Endo , a specialty drug firm based in Ireland, will pay $8.1 billion in cash and stock to acquire the U.S.-based generic drug firm Par Pharmaceutical . The combined business will have about $4.2 billion in annual sales.

Tags: par purchase pharmaceutical endo

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
02.05UK forecast for slowest growth of richest nations
02.05Uber faces 250m London black cab drivers lawsuit
02.05New Febreze Car Dials Up the Intensity in Automotive Air Care
02.05Monadnock Paper Mills appoints Chloe Jones
02.05The insect farmers turning to AI to help lower costs
01.05Knowing beats hoping
01.05Anderson & Vreeland acquires Adheso-Graphics
01.05Brazil issues favorable regulatory determination for PICs PRRS-resistant pig
More »